GL1X · GenesisL1 explorer

Research workbench

Structure of human THR160-phospho CDK2/CYCLIN a complexed with a 6-cyclohexylmethyloxy-2-anilino-purine inhibitor

Analyse Structure of human THR160-phospho CDK2/CYCLIN a complexed with a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1OI9
Type
protein
Length
1,104 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cell division protein kinase 2; Cyclin A2
EC
2.7.1.37
UniProt
P24941, P20248
Ligands
N20, MG
Pockets
14 · best druggability 0.81

Structure

x-ray diffraction · 4 distinct chains · 49% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACell division protein kinase 2 (EC 2.7.1.37)protein29635% helix, 17% strandP24941
BCyclin A2protein25867% helix, 0% strandP20248
CCell division protein kinase 2 (EC 2.7.1.37)protein29734% helix, 17% strandP24941
DCyclin A2protein25366% helix, 0% strandP20248

Ligands and binding sites

  • N20 · 6-cyclohexylmethyloxy-2-(4'-hydroxyanilino)purine · ligand · 2 copies · chains A, C
  • MG · Magnesium ion · metal · chains B
  • SGM · Monothioglycerol · additive · 2 copies · chains B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11250.810.9922empty
21140.800.9824empty
310590.790.8092empty
42230.680.8528N20
52260.660.8426N20

Interfaces

5 interfaces between chains.

  • A–B · 1758 Ų buried · 28 hydrogen bonds · protein-protein
  • C–D · 1690 Ų buried · 27 hydrogen bonds · protein-protein
  • B–C · 545 Ų buried · 3 hydrogen bonds · protein-protein
  • A–D · 494 Ų buried · 2 hydrogen bonds · protein-protein
  • A–C · 115 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified, 1 covalent (phosphorylation, additive adduct).

Compared structures

  • 1OI9 · Structure of human Thr160-phospho CDK2/cyclin A complexed with a… · the same entry in another collection · chain D against D, TM-score 1.00
  • P20248 · AlphaFold monomer V2.0 prediction for cyclin-A2 (P20248) · a predicted model of the same protein · chain B against A, TM-score 1.00
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain A against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.